Biotecnología: se sale de la pantalla

Fuente: investing.com



Gráfico mensual






Estos 10 valores representan el 58,32% del índice:

	Name	Average Vol. (3m)	Market Cap	Revenue	P/E Ratio	Beta
	Gilead	13.45M	168.34B	27.49B	13.01	0.78
	Amgen	3.52M	118.43B	20.58B	21.02	0.54
	Celgene	5.43M	95.88B	8.02B	41.3	0.99
	Biogen Inc	1.91M	92.03B	10.13B	28.24	0.93
	Regeneron Pharma	889.77K	55.38B	3.06B	170.06	0.89
	Shire	808.96K	50.77B	6.16B	14.56	0.66
	Alexion	1.29M	44.96B	2.27B	68.18	0.57
	Mylan	3.87M	34.82B	7.88B	32.73	1.21
	Illumina Inc	1.20M	31.91B	1.98B	76.46	0.97
	Vertex Pharmaceuticals	1.71M	30.28B	718.93M		0.2